Assessment of serum catalase, reduced glutathione, and superoxide dismutase activities and malondialdehyde levels in keratoconus patients

Background The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum. Methods The study i...

Full description

Saved in:
Bibliographic Details
Published inEye (London) Vol. 36; no. 10; pp. 2062 - 2066
Main Authors Tekin, Serek, Seven, Erbil
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.10.2022
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum. Methods The study included 50 patients diagnosed with keratoconus and 53 healthy age- and sex-matched control subjects. The keratoconus patients were grouped according to the four keratoconus stages based on the modified Krumeich keratoconus classification system. The CAT, GSH and SOD activities and MDA levels in the serum samples collected from the patient and control groups were compared. Results The mean serum CAT, GSH, SOD and MDA levels in the keratoconus group were determined to be 0.075 (0.074–0.078)U/L, 0.002 (0.001–0.006) mmol/ml, 1.56 (1.51–1.62)U/L and 1.69 (1.65–1.99) mmol/L, respectively, and those in the control group were determined to be 0.024 (0.013–0.037)U/L, 0.029 (0.018–0.049) mmol/ml, 4.13 (4.01–4.17) U/L and 0.74 (0.65–0.82) mmol/L. The serum GSH levels and SOD activity were significantly lower in the keratoconus group ( p  < 0.001 for both) than in the control group while the CAT activity and MDA levels were significantly higher ( p  < 0.001 for both). Conclusion The low serum GSH levels and SOD activity and the high CAT activity and MDA levels observed in this study suggest the presence of oxidative stress and inadequate antioxidant defence mechanisms in keratoconus patients. The studied parameters may offer auxiliary markers for use in the diagnosis and treatment of the keratoconus disease and in its potential therapeutic targets in the future.
AbstractList BackgroundThe aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum.MethodsThe study included 50 patients diagnosed with keratoconus and 53 healthy age- and sex-matched control subjects. The keratoconus patients were grouped according to the four keratoconus stages based on the modified Krumeich keratoconus classification system. The CAT, GSH and SOD activities and MDA levels in the serum samples collected from the patient and control groups were compared.ResultsThe mean serum CAT, GSH, SOD and MDA levels in the keratoconus group were determined to be 0.075 (0.074–0.078)U/L, 0.002 (0.001–0.006) mmol/ml, 1.56 (1.51–1.62)U/L and 1.69 (1.65–1.99) mmol/L, respectively, and those in the control group were determined to be 0.024 (0.013–0.037)U/L, 0.029 (0.018–0.049) mmol/ml, 4.13 (4.01–4.17) U/L and 0.74 (0.65–0.82) mmol/L. The serum GSH levels and SOD activity were significantly lower in the keratoconus group (p < 0.001 for both) than in the control group while the CAT activity and MDA levels were significantly higher (p < 0.001 for both).ConclusionThe low serum GSH levels and SOD activity and the high CAT activity and MDA levels observed in this study suggest the presence of oxidative stress and inadequate antioxidant defence mechanisms in keratoconus patients. The studied parameters may offer auxiliary markers for use in the diagnosis and treatment of the keratoconus disease and in its potential therapeutic targets in the future.
The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum.BACKGROUNDThe aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum.The study included 50 patients diagnosed with keratoconus and 53 healthy age- and sex-matched control subjects. The keratoconus patients were grouped according to the four keratoconus stages based on the modified Krumeich keratoconus classification system. The CAT, GSH and SOD activities and MDA levels in the serum samples collected from the patient and control groups were compared.METHODSThe study included 50 patients diagnosed with keratoconus and 53 healthy age- and sex-matched control subjects. The keratoconus patients were grouped according to the four keratoconus stages based on the modified Krumeich keratoconus classification system. The CAT, GSH and SOD activities and MDA levels in the serum samples collected from the patient and control groups were compared.The mean serum CAT, GSH, SOD and MDA levels in the keratoconus group were determined to be 0.075 (0.074-0.078)U/L, 0.002 (0.001-0.006) mmol/ml, 1.56 (1.51-1.62)U/L and 1.69 (1.65-1.99) mmol/L, respectively, and those in the control group were determined to be 0.024 (0.013-0.037)U/L, 0.029 (0.018-0.049) mmol/ml, 4.13 (4.01-4.17) U/L and 0.74 (0.65-0.82) mmol/L. The serum GSH levels and SOD activity were significantly lower in the keratoconus group (p < 0.001 for both) than in the control group while the CAT activity and MDA levels were significantly higher (p < 0.001 for both).RESULTSThe mean serum CAT, GSH, SOD and MDA levels in the keratoconus group were determined to be 0.075 (0.074-0.078)U/L, 0.002 (0.001-0.006) mmol/ml, 1.56 (1.51-1.62)U/L and 1.69 (1.65-1.99) mmol/L, respectively, and those in the control group were determined to be 0.024 (0.013-0.037)U/L, 0.029 (0.018-0.049) mmol/ml, 4.13 (4.01-4.17) U/L and 0.74 (0.65-0.82) mmol/L. The serum GSH levels and SOD activity were significantly lower in the keratoconus group (p < 0.001 for both) than in the control group while the CAT activity and MDA levels were significantly higher (p < 0.001 for both).The low serum GSH levels and SOD activity and the high CAT activity and MDA levels observed in this study suggest the presence of oxidative stress and inadequate antioxidant defence mechanisms in keratoconus patients. The studied parameters may offer auxiliary markers for use in the diagnosis and treatment of the keratoconus disease and in its potential therapeutic targets in the future.CONCLUSIONThe low serum GSH levels and SOD activity and the high CAT activity and MDA levels observed in this study suggest the presence of oxidative stress and inadequate antioxidant defence mechanisms in keratoconus patients. The studied parameters may offer auxiliary markers for use in the diagnosis and treatment of the keratoconus disease and in its potential therapeutic targets in the future.
Background The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum. Methods The study included 50 patients diagnosed with keratoconus and 53 healthy age- and sex-matched control subjects. The keratoconus patients were grouped according to the four keratoconus stages based on the modified Krumeich keratoconus classification system. The CAT, GSH and SOD activities and MDA levels in the serum samples collected from the patient and control groups were compared. Results The mean serum CAT, GSH, SOD and MDA levels in the keratoconus group were determined to be 0.075 (0.074–0.078)U/L, 0.002 (0.001–0.006) mmol/ml, 1.56 (1.51–1.62)U/L and 1.69 (1.65–1.99) mmol/L, respectively, and those in the control group were determined to be 0.024 (0.013–0.037)U/L, 0.029 (0.018–0.049) mmol/ml, 4.13 (4.01–4.17) U/L and 0.74 (0.65–0.82) mmol/L. The serum GSH levels and SOD activity were significantly lower in the keratoconus group ( p  < 0.001 for both) than in the control group while the CAT activity and MDA levels were significantly higher ( p  < 0.001 for both). Conclusion The low serum GSH levels and SOD activity and the high CAT activity and MDA levels observed in this study suggest the presence of oxidative stress and inadequate antioxidant defence mechanisms in keratoconus patients. The studied parameters may offer auxiliary markers for use in the diagnosis and treatment of the keratoconus disease and in its potential therapeutic targets in the future.
Author Seven, Erbil
Tekin, Serek
Author_xml – sequence: 1
  givenname: Serek
  orcidid: 0000-0002-6660-8313
  surname: Tekin
  fullname: Tekin, Serek
  email: drserektekin091@gmail.com
  organization: Department of Ophthalmology, Faculty of Medicine, Van Yuzuncu Yil University
– sequence: 2
  givenname: Erbil
  orcidid: 0000-0001-5629-291X
  surname: Seven
  fullname: Seven, Erbil
  organization: Department of Ophthalmology, Faculty of Medicine, Van Yuzuncu Yil University
BookMark eNp9kctuFDEQRS0URCaBH2BliQ2LNPjZ3d4gRREvKRIbkNhZbnfNjIPbHlzdI_IJ_DXOTBAii6xqUedW1b11Rk5STkDIS87ecCb7t6i4krJhgjeMd1o2_AlZcdW1jVZanZAVM5o1Qojvp-QM8Yax2uzYM3IqlWqF7tmK_L5EBMQJ0kzzmiKUZaLezS46hAtaYFw8jHQTl9nN21APuKAujRSXHZT8K4xAx4BT7SJQ5-ewD3MAPDCTizmNwcURtrcVjLCHiDQk-gOKm7PPaUG6c1WQZnxOnq5dRHhxX8_Jtw_vv159aq6_fPx8dXndeKX53PTGeG2EW3vOWmaG0fsOusE7LaTsx34NbOA9dM5U97yt4UBneqeGodNGai3Pybvj3N0yTDD6uru4aHclTK7c2uyC_b-TwtZu8t4aZYxpZR3w-n5AyT8XwNlOAT3E6BLkBa3Qbd3Y6QP66gF6k5eSqj0rOl4xoSSvVH-kfMmIBdbWh5p2DbvuD9FyZu_-bY__ttWSPfzb3knFA-lfH4-K5FGEFU4bKP-uekT1ByTXwdU
CitedBy_id crossref_primary_10_1016_j_jff_2025_106743
crossref_primary_10_1007_s13530_023_00183_8
crossref_primary_10_58854_jicm_1412375
crossref_primary_10_2147_IJGM_S375282
crossref_primary_10_1021_acsomega_2c05989
crossref_primary_10_3103_S0095452724050086
crossref_primary_10_3390_pharmaceutics14081582
crossref_primary_10_1016_j_tiv_2025_106037
crossref_primary_10_1007_s11356_022_24920_7
crossref_primary_10_1080_17469899_2024_2368801
crossref_primary_10_2478_acve_2024_0025
crossref_primary_10_3390_biomedicines11020292
crossref_primary_10_3389_fphar_2023_1235810
crossref_primary_10_1016_j_prmcm_2024_100399
crossref_primary_10_3390_ph17030381
crossref_primary_10_3390_ijms23031255
crossref_primary_10_3390_nu14040913
crossref_primary_10_1167_tvst_11_12_16
Cites_doi 10.1016/j.mehy.2015.02.017
10.1016/j.clae.2007.03.001
10.1167/iovs.04-1395
10.1167/iovs.11-7732
10.3389/fphar.2015.00098
10.1038/srep04608
10.1016/j.exer.2019.107897
10.1016/S0076-6879(84)05016-3
10.1155/2016/3164734
10.1038/eye.2013.262
10.1093/clinchem/34.3.497
10.3109/02713688709025227
10.1097/ICO.0000000000001018
10.1016/0891-5849(91)90192-6
10.1177/002215540205000306
10.3892/ol.2012.931
10.1016/j.mito.2017.05.009
10.1167/iovs.05-0828
10.1167/iovs.04-0549
10.3928/1081597X-20090401-07
10.4103/jovr.jovr_80_18
10.1016/S0891-5849(98)00095-1
ContentType Journal Article
Copyright The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2021
The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2021.
2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
Copyright_xml – notice: The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2021
– notice: The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2021.
– notice: 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
DBID AAYXX
CITATION
3V.
7TK
7X7
7XB
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1038/s41433-021-01753-1
DatabaseName CrossRef
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1476-5454
EndPage 2066
ExternalDocumentID PMC9499963
10_1038_s41433_021_01753_1
GroupedDBID ---
-Q-
.GJ
0R~
29G
2WC
36B
39C
3O-
4.4
406
53G
5RE
6PF
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAWTL
AAYZH
ABAKF
ABAWZ
ABBRH
ABCQX
ABDBE
ABFSG
ABJNI
ABLJU
ABRTQ
ABUWG
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACSTC
ACZOJ
ADBBV
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFFNX
AFHIU
AFKRA
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
ATHPR
AXYYD
AYFIA
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
E3Z
EBLON
EBS
EBX
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JZLTJ
KQ8
L7B
M1P
M7P
NQJWS
O9-
OK1
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
RNS
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
UKHRP
W2D
ZGI
ZXP
AAYXX
CITATION
3V.
7TK
7XB
8FE
8FH
8FK
AZQEC
DWQXO
GNUQQ
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
PUEGO
7X8
5PM
ID FETCH-LOGICAL-c451t-899c592afc10609bdcc7e7bca52338d8fe0b18e7a909516021e798a4bb7593553
IEDL.DBID 7X7
ISSN 0950-222X
1476-5454
IngestDate Thu Aug 28 05:03:03 EDT 2025
Fri Jul 11 12:45:03 EDT 2025
Sat Aug 23 14:59:39 EDT 2025
Tue Jul 01 03:00:37 EDT 2025
Thu Apr 24 23:02:29 EDT 2025
Mon Jul 21 06:08:36 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c451t-899c592afc10609bdcc7e7bca52338d8fe0b18e7a909516021e798a4bb7593553
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6660-8313
0000-0001-5629-291X
OpenAccessLink https://www.nature.com/articles/s41433-021-01753-1.pdf
PMID 34462580
PQID 2716792431
PQPubID 33647
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9499963
proquest_miscellaneous_2567987563
proquest_journals_2716792431
crossref_citationtrail_10_1038_s41433_021_01753_1
crossref_primary_10_1038_s41433_021_01753_1
springer_journals_10_1038_s41433_021_01753_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-10-01
PublicationDateYYYYMMDD 2022-10-01
PublicationDate_xml – month: 10
  year: 2022
  text: 2022-10-01
  day: 01
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationSubtitle The Scientific Journal of The Royal College of Ophthalmologists
PublicationTitle Eye (London)
PublicationTitleAbbrev Eye
PublicationYear 2022
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Beutler (CR11) 1963; 61
Behndig, Karlsson, Johansson, Brannstrom, Marklund (CR23) 2001; 42
Zhou, Sawaguchi, Twining, Sugar, Feder, Yue (CR16) 1998; 39
Pompella, Corti (CR20) 2015; 6
Arnal, Peris-Martínez, Menezo (CR3) 2011; 52
Karamichos, Hutcheon, Rich, Trinkaus-randall, Asara, Zieske (CR22) 2014; 4
Buddi, Lin, Atilano, Zorapapel, Kenney, Brown (CR4) 2002; 50
Balmus, Alexa, Ciuntu, Danielescu, Stoica, Cojocaru (CR24) 2020; 190
Dudakova, Liskova, Jirsova (CR15) 2015; 84
Nita, Grzybowski (CR1) 2016; 2016
Balasubramanian, Mohan, Pye, Willcox (CR17) 2012; 90
Atalla, Fernandez, Rao (CR18) 1987; 6
Kılıç, Bayraktar, Bayraktar, Kurt, Kavutçu (CR26) 2016; 35
Krumeich, Kezirian (CR9) 2009; 25
Esterbauer, Schaur, Zollner (CR27) 1991; 11
Aebi (CR10) 1984; 105
Chwa, Atilano, Reddy, Jordan, Kim, Kenney (CR14) 2006; 47
Kenney, Chwa, Atilano, Tran, Carballo, Saghizadeh (CR6) 2005; 46
Cantemir, Iuliana Alexa, Ciobica, Miruna Balmus, Antioch, Stoica (CR25) 2016; 67
Wagner, Barr, Zadnik (CR8) 2007; 30
Sun, Oberley, Li (CR12) 1988; 34
Atilano, Coskun, Chwa, Jordan, Reddy, Le (CR13) 2005; 46
Toprak, Kucukatay, Yildirim, Kilic-Toprak, Erkek (CR19) 2014; 28
Squadrito, Pryor (CR5) 1998; 25
Vallabh, Romano, Willoughby (CR2) 2017; 36
Atilano, Lee, Fukuhara, Chwa, Nesburn, Udar (CR7) 2019; 14
Zitka, Skalickova, Gumulec, Masarik, Adam, Hubalek (CR21) 2012; 4
A Cantemir (1753_CR25) 2016; 67
I Balmus (1753_CR24) 2020; 190
E Beutler (1753_CR11) 1963; 61
E Arnal (1753_CR3) 2011; 52
O Zitka (1753_CR21) 2012; 4
A Pompella (1753_CR20) 2015; 6
H Wagner (1753_CR8) 2007; 30
S Balasubramanian (1753_CR17) 2012; 90
M Nita (1753_CR1) 2016; 2016
L Atalla (1753_CR18) 1987; 6
Y Sun (1753_CR12) 1988; 34
H Aebi (1753_CR10) 1984; 105
R Kılıç (1753_CR26) 2016; 35
M Kenney (1753_CR6) 2005; 46
H Esterbauer (1753_CR27) 1991; 11
S Atilano (1753_CR13) 2005; 46
I Toprak (1753_CR19) 2014; 28
D Karamichos (1753_CR22) 2014; 4
R Buddi (1753_CR4) 2002; 50
J Krumeich (1753_CR9) 2009; 25
A Behndig (1753_CR23) 2001; 42
L Zhou (1753_CR16) 1998; 39
N Vallabh (1753_CR2) 2017; 36
M Chwa (1753_CR14) 2006; 47
L Dudakova (1753_CR15) 2015; 84
S Atilano (1753_CR7) 2019; 14
G Squadrito (1753_CR5) 1998; 25
References_xml – volume: 84
  start-page: 518
  year: 2015
  end-page: 24
  ident: CR15
  article-title: Is copper imbalance an environmental factor influencing keratoconus development?
  publication-title: Med Hypotheses
  doi: 10.1016/j.mehy.2015.02.017
– volume: 30
  start-page: 223
  year: 2007
  end-page: 32
  ident: CR8
  article-title: Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date
  publication-title: Cont Lens Anterior Eye
  doi: 10.1016/j.clae.2007.03.001
– volume: 46
  start-page: 1256
  year: 2005
  end-page: 63
  ident: CR13
  article-title: Accumulation of mitochondrial DNA damage in keratoconus corneas
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.04-1395
– volume: 67
  start-page: 1538
  year: 2016
  end-page: 41
  ident: CR25
  article-title: Evaluation of antioxidant enzymes in keratoconus
  publication-title: Rev Chim
– volume: 52
  start-page: 8592
  year: 2011
  end-page: 7
  ident: CR3
  article-title: Oxidative stress in keratoconus?
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.11-7732
– volume: 6
  start-page: 98
  year: 2015
  ident: CR20
  article-title: The changing faces of glutathione, a cellular protagonist
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2015.00098
– volume: 4
  year: 2014
  ident: CR22
  article-title: In vitro model suggests oxidative stress involved in keratoconus disease
  publication-title: Sci Rep.
  doi: 10.1038/srep04608
– volume: 190
  start-page: 107897
  year: 2020
  ident: CR24
  article-title: Oxidative stress markers dynamics in keratoconus patients’ tears before and after corneal collagen crosslinking procedure
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2019.107897
– volume: 105
  start-page: 121
  year: 1984
  end-page: 6
  ident: CR10
  article-title: Catalase in vitro
  publication-title: Methods Enzymol
  doi: 10.1016/S0076-6879(84)05016-3
– volume: 2016
  start-page: 3164734
  year: 2016
  ident: CR1
  article-title: The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior
  publication-title: Oxid Med Cell Longev
  doi: 10.1155/2016/3164734
– volume: 28
  start-page: 285
  year: 2014
  ident: CR19
  article-title: Increased systemic oxidative stress in patients with keratoconus
  publication-title: Eye
  doi: 10.1038/eye.2013.262
– volume: 34
  start-page: 497
  year: 1988
  end-page: 500
  ident: CR12
  article-title: A simple method for clinical assay of superoxide dismutase
  publication-title: Clin Chem
  doi: 10.1093/clinchem/34.3.497
– volume: 6
  start-page: 1181
  year: 1987
  end-page: 7
  ident: CR18
  article-title: Immunohistochemical localization of catalase in ocular tissue
  publication-title: Curr Eye Res
  doi: 10.3109/02713688709025227
– volume: 35
  start-page: 1512
  year: 2016
  end-page: 5
  ident: CR26
  article-title: Evaluation of serum superoxide dismutase activity, malondialdehyde, and zinc and copper levels in patients with keratoconus
  publication-title: Cornea
  doi: 10.1097/ICO.0000000000001018
– volume: 11
  start-page: 81
  year: 1991
  end-page: 128
  ident: CR27
  article-title: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
  publication-title: Free Radic Biol Med
  doi: 10.1016/0891-5849(91)90192-6
– volume: 50
  start-page: 341
  year: 2002
  end-page: 51
  ident: CR4
  article-title: Evidence of oxidative stress in human corneal diseases
  publication-title: J Histochem Cytochem
  doi: 10.1177/002215540205000306
– volume: 39
  start-page: 1117
  year: 1998
  end-page: 24
  ident: CR16
  article-title: Expression of degradative enzymes and protease inhibitors in corneas with keratoconus
  publication-title: Invest Ophthalmol Vis Sci
– volume: 4
  start-page: 1247
  issue: Dec
  year: 2012
  end-page: 53
  ident: CR21
  article-title: Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients
  publication-title: Oncol Lett
  doi: 10.3892/ol.2012.931
– volume: 36
  start-page: 103
  year: 2017
  end-page: 13
  ident: CR2
  article-title: Mitochondrial dysfunction and oxidative stress in corneal disease
  publication-title: Mitochondrion
  doi: 10.1016/j.mito.2017.05.009
– volume: 47
  start-page: 1902
  year: 2006
  end-page: 10
  ident: CR14
  article-title: Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.05-0828
– volume: 46
  start-page: 823
  year: 2005
  end-page: 32
  ident: CR6
  article-title: Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.04-0549
– volume: 25
  start-page: 357
  year: 2009
  end-page: 65
  ident: CR9
  article-title: Circular keratotomy to reduce astigmatism and improve vision in stage I and II keratoconus
  publication-title: j Refract Surg
  doi: 10.3928/1081597X-20090401-07
– volume: 42
  start-page: 2293
  year: 2001
  end-page: 6
  ident: CR23
  article-title: Superoxide dismutase isoenzymes in the normal and diseased human cornea
  publication-title: Invest Ophthalmol Vis Sci
– volume: 90
  start-page: 45
  issue: Jun
  year: 2012
  ident: CR17
  article-title: Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus
  publication-title: Acta Ophthalmol
– volume: 14
  start-page: 62
  year: 2019
  ident: CR7
  article-title: Corneal oxidative damage in keratoconus cells due to decreased oxidant elimination from modified expression levels of SOD enzymes, PRDX6, SCARA3
  publication-title: J Ophthalmic Vis Res
  doi: 10.4103/jovr.jovr_80_18
– volume: 61
  start-page: 882
  year: 1963
  end-page: 8
  ident: CR11
  article-title: Improved method for the determination of blood glutathione
  publication-title: J Lab Clin Med
– volume: 25
  start-page: 392
  year: 1998
  end-page: 403
  ident: CR5
  article-title: Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide
  publication-title: Free Radic Biol Med
  doi: 10.1016/S0891-5849(98)00095-1
– volume: 42
  start-page: 2293
  year: 2001
  ident: 1753_CR23
  publication-title: Invest Ophthalmol Vis Sci
– volume: 35
  start-page: 1512
  year: 2016
  ident: 1753_CR26
  publication-title: Cornea
  doi: 10.1097/ICO.0000000000001018
– volume: 61
  start-page: 882
  year: 1963
  ident: 1753_CR11
  publication-title: J Lab Clin Med
– volume: 6
  start-page: 98
  year: 2015
  ident: 1753_CR20
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2015.00098
– volume: 34
  start-page: 497
  year: 1988
  ident: 1753_CR12
  publication-title: Clin Chem
  doi: 10.1093/clinchem/34.3.497
– volume: 14
  start-page: 62
  year: 2019
  ident: 1753_CR7
  publication-title: J Ophthalmic Vis Res
  doi: 10.4103/jovr.jovr_80_18
– volume: 46
  start-page: 823
  year: 2005
  ident: 1753_CR6
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.04-0549
– volume: 36
  start-page: 103
  year: 2017
  ident: 1753_CR2
  publication-title: Mitochondrion
  doi: 10.1016/j.mito.2017.05.009
– volume: 6
  start-page: 1181
  year: 1987
  ident: 1753_CR18
  publication-title: Curr Eye Res
  doi: 10.3109/02713688709025227
– volume: 105
  start-page: 121
  year: 1984
  ident: 1753_CR10
  publication-title: Methods Enzymol
  doi: 10.1016/S0076-6879(84)05016-3
– volume: 39
  start-page: 1117
  year: 1998
  ident: 1753_CR16
  publication-title: Invest Ophthalmol Vis Sci
– volume: 67
  start-page: 1538
  year: 2016
  ident: 1753_CR25
  publication-title: Rev Chim
– volume: 25
  start-page: 392
  year: 1998
  ident: 1753_CR5
  publication-title: Free Radic Biol Med
  doi: 10.1016/S0891-5849(98)00095-1
– volume: 90
  start-page: 45
  issue: Jun
  year: 2012
  ident: 1753_CR17
  publication-title: Acta Ophthalmol
– volume: 4
  start-page: 1247
  issue: Dec
  year: 2012
  ident: 1753_CR21
  publication-title: Oncol Lett
  doi: 10.3892/ol.2012.931
– volume: 47
  start-page: 1902
  year: 2006
  ident: 1753_CR14
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.05-0828
– volume: 11
  start-page: 81
  year: 1991
  ident: 1753_CR27
  publication-title: Free Radic Biol Med
  doi: 10.1016/0891-5849(91)90192-6
– volume: 50
  start-page: 341
  year: 2002
  ident: 1753_CR4
  publication-title: J Histochem Cytochem
  doi: 10.1177/002215540205000306
– volume: 4
  year: 2014
  ident: 1753_CR22
  publication-title: Sci Rep.
  doi: 10.1038/srep04608
– volume: 25
  start-page: 357
  year: 2009
  ident: 1753_CR9
  publication-title: j Refract Surg
  doi: 10.3928/1081597X-20090401-07
– volume: 84
  start-page: 518
  year: 2015
  ident: 1753_CR15
  publication-title: Med Hypotheses
  doi: 10.1016/j.mehy.2015.02.017
– volume: 190
  start-page: 107897
  year: 2020
  ident: 1753_CR24
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2019.107897
– volume: 28
  start-page: 285
  year: 2014
  ident: 1753_CR19
  publication-title: Eye
  doi: 10.1038/eye.2013.262
– volume: 46
  start-page: 1256
  year: 2005
  ident: 1753_CR13
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.04-1395
– volume: 30
  start-page: 223
  year: 2007
  ident: 1753_CR8
  publication-title: Cont Lens Anterior Eye
  doi: 10.1016/j.clae.2007.03.001
– volume: 2016
  start-page: 3164734
  year: 2016
  ident: 1753_CR1
  publication-title: Oxid Med Cell Longev
  doi: 10.1155/2016/3164734
– volume: 52
  start-page: 8592
  year: 2011
  ident: 1753_CR3
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.11-7732
SSID ssj0014770
Score 2.4684734
Snippet Background The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced...
BackgroundThe aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced...
The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione...
SourceID pubmedcentral
proquest
crossref
springer
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 2062
SubjectTerms 692/308/53/2423
692/53/2423
692/699/3161/3163
Antioxidants
Catalase
Glutathione
Keratoconus
Laboratory Medicine
Malondialdehyde
Medicine
Medicine & Public Health
Ophthalmology
Oxidative stress
Patients
Pharmaceutical Sciences/Technology
Superoxide dismutase
Surgery
Surgical Oncology
Therapeutic targets
Title Assessment of serum catalase, reduced glutathione, and superoxide dismutase activities and malondialdehyde levels in keratoconus patients
URI https://link.springer.com/article/10.1038/s41433-021-01753-1
https://www.proquest.com/docview/2716792431
https://www.proquest.com/docview/2567987563
https://pubmed.ncbi.nlm.nih.gov/PMC9499963
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9swED62FsZeRtttLFtbVNjbaupfsuSnkpSGUmgYY4W8GVlS1tDE7up4rH9C_-veKYpDCu2LDbaMhO_su9N39x3Ad9QDw22WYmwi8RCrMFCxDAODtt2ElKSjCNG9GmUX1-nlmI_9hlvj0ypX_0T3oza1pj3yk1gQYBCjvTu9-xtQ1yhCV30LjbewTdRllNIlxl3AFaXCNYtDLyIM0A6OfdFMmMiTJkVHgRBMCqbRZQ-iTcO09jaf50o-A0ydHRruwAfvQLL-UuK78MZWe_DuykPkH-Gx33FtsnrCUMPaOXObNGivjtk9UbVaw_6gxlHiYV3hRVUZ1rREGf5_aiwz02ZOqdqWUdXDP8e56sbM1ayuqNLE2JsHHDijjKOGTSt2S9zMNcbWbcM8VWvzCa6H57_PLgLfbyHQKY8WAYZemuexmmiME8O8NFoLK0qtMFhNpJETG5aRtELl5Jdl-O6syKVKy1JwomlPPsNWhcv-Akwnpc24inNuqNieK2niUqaRSlIlJ4ntQbR62YX2ZOTUE2NWOFA8kcVSQAVOUjgBFVEPfnTP3C2pOF4dvb-SYeE_y6ZYK1EPjrrb-EERSqIqW7c4hhMwJXiW9EBsyL6blSi5N-9U0xtHzZ27ABKfPF5pyXryl9f69fW1foP3MRVduBTCfdha3Lf2AF2hRXno9P0QtvvDwWCE58H56OevJ4luCow
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-NTgJeEH9FYYCR4IlFS5w4cR4QGrCpY2uF0Cb1LTi2yyraZCwNsI_Al-EzcucmqTqJve0lD40dW72L7365u98BvEI9MMLGEWITiReufE9x6XsGbbvxKUlHUUR3OIoHJ9GnsRhvwN-2FobSKtsz0R3UptT0jXyHJxQw4Gjv3p398KhrFEVX2xYaS7U4tBe_ELJVbw8-onxfc76_d_xh4DVdBTwdiWDhIcDQIuVqohEN-WlutE5skmuFkCyURk6snwfSJiol7yNGG2iTVKoozxNBZOQhPvcGbEYhQpkebL7fG33-0sUtosS1p8OZvoeWd9yU6fih3KkidE0oZkrwHUGCF6ybwpV_ezk781KI1lm-_btwp3FZ2e5Sx-7Bhi3uw81hE5R_AH92O3ZPVk4Y6nQ9Z-6zEFrIbXZO5LDWsG-o45TqWBb4oyoMq2oiKf89NZaZaTWn5HDLqM7ip2N5dWPmalYWVNti7OkFDpxRjlPFpgX7TmzQJaL5umINOWz1EE6uRRaPoFfgth8D02FuY6F4KgyV9wslDc9lFKgwUnIS2j4E7Z-d6Yb-nLpwzDIXhg9lthRQhotkTkBZ0Ic33ZyzJfnHlaO3WhlmzUFQZSu17cPL7ja-whSXUYUtaxwjKBSWiDjsQ7Im-25VIgFfv1NMTx0ZeOogK87cbrVktfj_9_rk6r2-gFuD4-FRdnQwOnwKtzmVfLgExi3oLc5r-wwdsUX-vNF-Bl-v-4X7B6l0RN8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-NIU28IP6KwgZGgicWNXHi2HlA08SoNsYmHpjUt-DEzlbRJmNpgH2EfaV9Ou7cJFUnsbe99KGxa6t39t0vd_c7gHeoB0bYOEJsovCDa9_TXPmeQdtufErS0RTRPTqO90-iL2MxXoPrrhaG0iq7O9Fd1KbK6R35kEsKGHC0d8OiTYv4tjfaOf_lUQcpirR27TQWKnJoL_8gfKs_HuyhrN9zPvr8_dO-13YY8PJIBHMPwUYuEq6LHJGRn2Qmz6WVWa4RnoXKqML6WaCs1Al5IjHaQysTpaMsk4KIyUP83XtwX4YioDMmxz3YCyLpGtXhPN9DGzxuC3b8UA3rCJ0Uip4SkEe44AWrRnHp6d7M07wRrHU2cPQIHrbOK9tdaNtjWLPlE9g4asPzT-Fqt-f5ZFXBULubGXMviNBWbrMLoom1hp2itlPSY1Xil7o0rG6IrvzvxFhmJvWM0sQto4qL347v1Y2Z6WlVUpWLsWeXOHBK2U41m5TsJ_FCV4jrm5q1NLH1Mzi5E0k8h_USt_0CWB5mNhaaJ8JQob_QyvBMRYEOI62K0A4g6P7sNG-J0KkfxzR1AflQpQsBpbhI6gSUBgP40M85X9CA3Dp6s5Nh2l4JdbpU4AG87R_jYaYIjS5t1eAYQUExKeJwAHJF9v2qRAe--qScnDla8MSBV5y53WnJcvH_7_Xl7Xt9Axt4zNKvB8eHr-ABp9oPl8m4Cevzi8ZuoUc2z1471Wfw467P2j8xwkev
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+serum+catalase%2C+reduced+glutathione%2C+and+superoxide+dismutase+activities+and+malondialdehyde+levels+in+keratoconus+patients&rft.jtitle=Eye+%28London%29&rft.au=Tekin%2C+Serek&rft.au=Seven%2C+Erbil&rft.date=2022-10-01&rft.pub=Nature+Publishing+Group&rft.issn=0950-222X&rft.eissn=1476-5454&rft.volume=36&rft.issue=10&rft.spage=2062&rft.epage=2066&rft_id=info:doi/10.1038%2Fs41433-021-01753-1&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-222X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-222X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-222X&client=summon